Homozygous familial hypercholesterolemia with stenosis of the left anterior descending coronary artery successfully treated with weekly low‐density lipoprotein apheresis for 16 years without percutaneous coronary intervention
Abstract We successfully treated a patient with homozygous familial hypercholesterolemia (HoFH) with stable coronary arterial disease using optimal medical therapy and low‐density lipoprotein (LDL) apheresis for 16 years without percutaneous coronary intervention or bypass surgery. Intensive LDL low...
Main Authors: | Takanori Yasu, Masahiro Shimoyama, Hiroshi Wada, Tomohiro Iwakura, Shigeru Toyoda, Atsuhiko Kawabe, Takushi Sugiyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2299 |
Similar Items
-
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012-11-01) -
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01) -
Role of lipoprotein apheresis in the management of familial hypercholesterolemia
by: Shamanna Seshadri Iyengar, et al.
Published: (2021-01-01) -
The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
by: Muhammet Bulut, et al.
Published: (2020-01-01) -
Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01)